Federal Register / Vol. 65, No. 89 / Monday, May 8, 2000 / Notices 26621

Drive, Natcher Building, Rm. 4AN44F,

National Institute of Dental & Craniofacial

Res., Bethesda, MD 20892, (301) 594–2372.

Name of Committee: National Instiute of

Dental and Craniofacial Research Special

Emphasis Panel 00–65, Review of R01.

Date: June 12, 2000.

Time: 2 p.m. to 4 p.m.

Agenda: To review and evaluate grant

applications.

Place: Natcher Building, Rm. 4AN44F,

Bethesda, MD 20892 (Telephone Conference

Call).

Contact Person: Anna Sandberg, PhD,

Scientific Review Administrator, National

Institute of Dental & Craniofacial Res., 45

Center Drive, Natcher Building, Rm 4AN44F,

Bethesda, MD 20892.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel 00–55, Review of R01.

Date: June 13, 2000.

Time: 1:30 p.m. to 3:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Natcher Building, Rm. 4AN44F,

Bethesda, MD 20892 (Telephone Conference

Call).

Contact Person: Anna Sandberg, PhD,

Scientific Review Administrator, National

Institute of Dental & Craniofacial Res., 45

Center Drive, Natcher Building, Rm. 4AN44F,

Bethesda, MD 20892.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel 00–55, Review of R01.

Date: June 13, 2000.

Place: Natcher Building, Rm. 4AN44F,

Bethesda, MD 20892 (Telephone Conference

Call).

Contact Person: Anna Sandberg, PhD,

Scientific Review Administrator, National

Institute of Dental & Craniofacial Res., 45

Center Drive, Natcher Building, Rm. 4AN44F,

Bethesda, MD 20892.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel 00–52, Applicant Interview,

P01.

Date: June 18–19, 2000.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: Pooks Hill Marriott, 5151 Pooks Hill

Road, Bethesda, MD 20814.

Contact Person: Yujing Liu, Scientific

Review Administrator, National Institute of

Dental & Craniofacial Res., 45 Center Drive,

Natcher Building, Rm. 4AN44F, Bethesda,

MD 20892.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel 00–47, Applicant Interview,

U01s.

Date: July 26–27, 2000.

Time: 8 a.m. to 5 p.m.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: Ramada Inn, 8400 Wisconsin

Avenue, Bethesda, MD 20814.

Contact Person: Philip Washko, PhD, DMD,

Scientific Review Administrator, 4500 Center

Drive, Natcher Building, Rm. 4AN44F,

National Institutes of Health, Bethesda, MD

20892, (301) 594–2372.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.121, Oral Diseases and

Disorders Research, National Institutes of

Health, HHS)

Dated: May 1, 2000.

Anna Snouffer,

Acting Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–11435 Filed 5–5–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Environmental

Health Sciences; Amended Notice of

Meeting

Notice is hereby given of a change in

the meeting of the National Advisory

Environmental Health Sciences Council,

May 15, 2000, 8:30 AM to May 16, 2000,

2:00 PM, Building 31C, Conference

Room 6, National Institutes of Health,

3100 Center Drive, Bethesda, MD, 20892

which was published in the Federal

Register on April 13, 2000, 65 FR 19916.

The NAEHSC meeting will be held for

one day on May 15, 2000. The Open and

Closed Sessions will be as follows:

Open 8:30 a.m. to 1:15 p.m. and Closed

1:30 p.m. to 4:30 p.m. The meeting is

partially Closed to the public.

Dated: May 1, 2000.

Anna Snouffer,

Acting Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–11436 Filed 5–5–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel Clinical

Trials Network.

Date: May 18–19, 2000.

Time: 8:30 a.m. to 3:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: Radisson Barcelo Hotel, 2121 P

Street, NW, Washington, DC 20037.

Contact Person: Susan L. Coyle, PhD,

Chief, Clinical, Epidemiological and Applied

Sciences Review Branch, Office of

Extramural Affairs, National Institute on

Drug Abuse, National Institutes of Health,

DHHS, 6001 Executive Boulevard, Room

3158, MSC 9547, Bethesda, MD 20892–9547,

(301) 443–2620.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: May 1, 2000.

Anna Snouffer,

Acting Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–11437 Filed 5–5–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel

‘‘Screening Compounds for Utility as Cocaine

Pharmacotherapies Using the Rat SelfAdministration Test’’.

Date: May 17, 2000.

Time: 9 a.m. to 2 p.m.

Agenda: To review and evaluate contract

proposals.